| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Unité INSERM 422 (Drs. Delacourte, David, Sergeant, Buée, and Vermersch, and A. Wattez), Lille; Gerontology Clinic (Drs. David, Ghozali, Fallet-Bianco, and Di Menza), Emile Roux Hospital, Limeil Brévannes; and Memory Clinic (Drs. Pasquier, Lebert, and Petit), Department of Neurology, CHU&U, Lille, France.
Address correspondence and reprint requests to Dr. A. Delacourte, Unité INSERM 422, Place de Verdun, 59045 Lille, Cedex, France.
OBJECTIVE: To determine the spatiotemporal mapping of neurofibrillary degeneration (NFD) in normal aging and the different stages of AD.
BACKGROUND: The pathophysiologic significance of AD lesions, namely amyloid plaques and neurofibrillary tangles, is still unclear, especially their interrelationship and their link with cognitive impairment.
METHODS: The study included 130 patients of various ages and different cognitive statuses, from nondemented control subjects (n = 60, prospective study) to patients with severe definite AD. Paired helical filaments (PHF)-tau and Aß were used as biochemical and histologic markers of NFD and amyloid plaques, respectively.
RESULTS: NFD with PHF-tau was systematically present in variable amounts in the hippocampal region of nondemented patients age >75 years. When NFD was found in other brain areas, it was always along a stereotyped, sequential, hierarchical pathway. The progression was categorized into 10 stages according to the brain regions affected: transentorhinal cortex (S1), entorhinal (S2), hippocampus (S3), anterior temporal cortex (S4), inferior temporal cortex (S5), medium temporal cortex (S6), polymodal association areas (prefrontal, parietal inferior, temporal superior) (S7), unimodal areas (S8), primary motor (S9a) or sensory (S9b, S9c) areas, and all neocortical areas (S10). Up to stage 6, the disease could be asymptomatic. In all cases studied here, stage 7 individuals with two polymodal association areas affected by tau pathologic states were cognitively impaired.
CONCLUSIONS: The relationship between NFD and Alzheimer-type dementia, and the criteria for a biochemical diagnosis of AD, are documented, and an association between AD and the extent of NFD in defined brain areas is shown.
This article has been cited by other articles:
|
|
 |
|
  B. Frost, R. L. Jacks, and M. I. Diamond Propagation of Tau Misfolding from the Outside to the Inside of a Cell J. Biol. Chem., May 8, 2009; 284(19): 12845 - 12852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Rudinskiy, Y. Grishchuk, A. Vaslin, J. Puyal, A. Delacourte, H. Hirling, P. G. H. Clarke, and R. Luthi-Carter Calpain Hydrolysis of {alpha}- and {beta}2-Adaptins Decreases Clathrin-dependent Endocytosis and May Promote Neurodegeneration J. Biol. Chem., May 1, 2009; 284(18): 12447 - 12458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Huali Wang, E. Golob, A. Bert, Ke Nie, Yong Chu, M. B. Dick, M. Mandelkern, and M.-Y. Su Alterations in Regional Brain Volume and Individual MRI-Guided Perfusion in Normal Control, Stable Mild Cognitive Impairment, and MCI-AD Converter J Geriatr Psychiatry Neurol, March 1, 2009; 22(1): 35 - 45. [Abstract] [PDF]
|
|
|
|
 |
|
 L. De Beaumont, H. Theoret, D. Mongeon, J. Messier, S. Leclerc, S. Tremblay, D. Ellemberg, and M. Lassonde Brain function decline in healthy retired athletes who sustained their last sports concussion in early adulthood Brain, March 1, 2009; 132(3): 695 - 708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Colliot, G. Chetelat, M. Chupin, B. Desgranges, B. Magnin, H. Benali, B. Dubois, L. Garnero, F. Eustache, and S. Lehericy Discrimination between Alzheimer Disease, Mild Cognitive Impairment, and Normal Aging by Using Automated Segmentation of the Hippocampus Radiology, July 1, 2008; 248(1): 194 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kinkingnehun, M. Sarazin, S. Lehericy, E. Guichart-Gomez, T. Hergueta, and B. Dubois VBM anticipates the rate of progression of Alzheimer disease: A 3-year longitudinal study Neurology, June 3, 2008; 70(23): 2201 - 2211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sarazin, C. Berr, J. De Rotrou, C. Fabrigoule, F. Pasquier, S. Legrain, B. Michel, M. Puel, M. Volteau, J. Touchon, et al. Amnestic syndrome of the medial temporal type identifies prodromal AD: A longitudinal study Neurology, November 6, 2007; 69(19): 1859 - 1867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Truchot, S. N. Costes, L. Zimmer, B. Laurent, D. Le Bars, C. Thomas-Anterion, B. Croisile, B. Mercier, M. Hermier, A. Vighetto, et al. Up-regulation of hippocampal serotonin metabolism in mild cognitive impairment Neurology, September 4, 2007; 69(10): 1012 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. A. Mondadori, D. J. -F. de Quervain, A. Buchmann, H. Mustovic, M. A. Wollmer, C. F. Schmidt, P. Boesiger, C. Hock, R. M. Nitsch, A. Papassotiropoulos, et al. Better Memory and Neural Efficiency in Young Apolipoprotein E {varepsilon}4 Carriers Cereb Cortex, August 1, 2007; 17(8): 1934 - 1947. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bombois, C.-A. Maurage, M. Gompel, V. Deramecourt, M.-A. Mackowiak-Cordoliani, R. S. Black, R. Lavielle, A. Delacourte, and F. Pasquier Absence of beta-Amyloid Deposits After Immunization in Alzheimer Disease With Lewy Body Dementia Arch Neurol, April 1, 2007; 64(4): 583 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. F. Jones, J. Barnes, H. B.M. Uylings, N. C. Fox, C. Frost, M. P. Witter, and P. Scheltens Differential Regional Atrophy of the Cingulate Gyrus in Alzheimer Disease: A Volumetric MRI Study Cereb Cortex, December 1, 2006; 16(12): 1701 - 1708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. A. Mondadori, A. Buchmann, H. Mustovic, C. F. Schmidt, P. Boesiger, R. M. Nitsch, C. Hock, J. Streffer, and K. Henke Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years Brain, November 1, 2006; 129(11): 2908 - 2922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Ray, H. Wang, Y. Chu, Y.-F. Chen, A. Bert, A. N. Hasso, and M.-Y. Su Mild Cognitive Impairment: Apparent Diffusion Coefficient in Regional Gray Matter and White Matter Structures Radiology, October 1, 2006; 241(1): 197 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Guedj, E. J. Barbeau, M. Didic, O. Felician, C. de Laforte, M. Ceccaldi, O. Mundler, and M. Poncet Identification of subgroups in amnestic mild cognitive impairment. Neurology, July 25, 2006; 67(2): 356 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.J. House, T.G. St. Pierre, J.K. Foster, R.N. Martins, and R. Clarnette Quantitative MR Imaging R2 Relaxometry in Elderly Participants Reporting Memory Loss. AJNR Am. J. Neuroradiol., February 1, 2006; 27(2): 430 - 439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mosconi, W. -H. Tsui, S. De Santi, J. Li, H. Rusinek, A. Convit, Y. Li, M. Boppana, and M. J. de Leon Reduced hippocampal metabolism in MCI and AD: Automated FDG-PET image analysis Neurology, June 14, 2005; 64(11): 1860 - 1867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Vandenberghe and J Tournoy Cognitive aging and Alzheimer's disease Postgrad. Med. J., June 1, 2005; 81(956): 343 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A F Wright Neurogenetics II: complex disorders J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 623 - 631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. L. Ber, M. Martinez, D. Campion, A. Laquerriere, C. Betard, G. Bassez, C. Girard, P. Saugier-Veber, G. Raux, N. Sergeant, et al. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24 Brain, September 1, 2004; 127(9): 1979 - 1992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Eustache, P. Piolino, B. Giffard, F. Viader, V. D. L. Sayette, J.-C. Baron, and B. Desgranges 'In the course of time': a PET study of the cerebral substrates of autobiographical amnesia in Alzheimer's disease Brain, July 1, 2004; 127(7): 1549 - 1560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Barbeau, M. Didic, E. Tramoni, O. Felician, S. Joubert, A. Sontheimer, M. Ceccaldi, and M. Poncet Evaluation of visual recognition memory in MCI patients Neurology, April 27, 2004; 62(8): 1317 - 1322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. AVILA, J. J. LUCAS, M. PEREZ, and F. HERNANDEZ Role of Tau Protein in Both Physiological and Pathological Conditions Physiol Rev, April 1, 2004; 84(2): 361 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mosconi, A. Pupi, M. T. R. De Cristofaro, M. Fayyaz, S. Sorbi, and K. Herholz Functional Interactions of the Entorhinal Cortex: An 18F-FDG PET Study on Normal Aging and Alzheimer's Disease J. Nucl. Med., March 1, 2004; 45(3): 382 - 392. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. J Miller and R. Chacko The Role of Cholesterol and Statins in Alzheimer's Disease Ann. Pharmacother., January 1, 2004; 38(1): 91 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Chetelat, B. Desgranges, V. de la Sayette, F. Viader, K. Berkouk, B. Landeau, C. Lalevee, F. Le Doze, B. Dupuy, D. Hannequin, et al. Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment Brain, September 1, 2003; 126(9): 1955 - 1967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Thompson, K. M. Hayashi, G. de Zubicaray, A. L. Janke, S. E. Rose, J. Semple, D. Herman, M. S. Hong, S. S. Dittmer, D. M. Doddrell, et al. Dynamics of Gray Matter Loss in Alzheimer's Disease J. Neurosci., February 1, 2003; 23(3): 994 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Weill-Engerer, J.-P. David, V. Sazdovitch, P. Liere, B. Eychenne, A. Pianos, M. Schumacher, A. Delacourte, E.-E. Baulieu, and Y. Akwa Neurosteroid Quantification in Human Brain Regions: Comparison between Alzheimer's and Nondemented Patients J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5138 - 5143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Dixon, K. M. Bradley, M. M. Budge, P. Styles, and A. D. Smith Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease Brain, October 1, 2002; 125(10): 2332 - 2341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Fillit The Role of Hormone Replacement Therapy in the Prevention of Alzheimer Disease Arch Intern Med, September 23, 2002; 162(17): 1934 - 1942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Delacourte, N. Sergeant, D. Champain, A. Wattez, C.-A. Maurage, F. Lebert, F. Pasquier, and J.-P. David Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease Neurology, August 13, 2002; 59(3): 398 - 407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Bradley, V. T. O'Sullivan, N. D. W. Soper, Z. Nagy, E. M.-F. King, A. D. Smith, and B. J. Shepstone Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease Brain, August 1, 2002; 125(8): 1772 - 1781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chantal, M. Labelle, R. W. Bouchard, C. M. J. Braun, and Y. Boulanger Correlation of Regional Proton Magnetic Resonance Spectroscopic Metabolic Changes With Cognitive Deficits in Mild Alzheimer Disease Arch Neurol, June 1, 2002; 59(6): 955 - 962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Desgranges, J.-C. Baron, C. Lalevee, B. Giffard, F. Viader, V. de la Sayette, and F. Eustache The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: relationship to degree of deterioration Brain, May 1, 2002; 125(5): 1116 - 1124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sun, X. V. Nguyen, and G. Bing Comparative Analysis of an Improved Thioflavin-S Stain, Gallyas Silver Stain, and Immunohistochemistry for Neurofibrillary Tangle Demonstration on the Same Sections J. Histochem. Cytochem., April 1, 2002; 50(4): 463 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Caparros-Lefebvre, N. Sergeant, A. Lees, A. Camuzat, S. Daniel, A. Lannuzel, A. Brice, E. Tolosa, A. Delacourte, and C. Duyckaerts Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy Brain, April 1, 2002; 125(4): 801 - 811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Harding, G. A. Broe, and G. M. Halliday Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe Brain, February 1, 2002; 125(2): 391 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Morris, S. Al-Sarraj, C. Schwab, K. Gwinn-Hardy, J. Perez-Tur, N. W. Wood, J. Hardy, A. J. Lees, P. L. McGeer, S. E. Daniel, et al. A clinical and pathological study of motor neurone disease on Guam Brain, November 1, 2001; 124(11): 2215 - 2222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K Meguro, C LeMestric, B Landeau, B Desgranges, F Eustache, and J-C Baron Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative study J. Neurol. Neurosurg. Psychiatry, September 1, 2001; 71(3): 315 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sergeant, B. Sablonniere, S. Schraen-Maschke, A. Ghestem, C.-A. Maurage, A. Wattez, P. Vermersch, and A. Delacourte Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1 Hum. Mol. Genet., September 1, 2001; 10(19): 2143 - 2155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kantarci, C. R. Jack Jr, Y. C. Xu, N. G. Campeau, P. C. O’Brien, G. E. Smith, R. J. Ivnik, B. F. Boeve, E. Kokmen, E. G. Tangalos, et al. Mild Cognitive Impairment and Alzheimer Disease: Regional Diffusivity of Water Radiology, April 1, 2001; 219(1): 101 - 107. [Abstract] [Full Text]
|
|
|
|
|
|
K. Kantarci, C. R. Jack Jr., Y. C. Xu, N. G. Campeau, P. C. O'Brien, G. E. Smith, R. J. Ivnik, B. F. Boeve, E. Kokmen, E. G. Tangalos, et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study Neurology, July 25, 2000; 55(2): 210 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Ball and A. Delacourte The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease Neurology, January 25, 2000; 54(2): 538 - 538. [Full Text] [PDF]
|
|
|
|
|
|
K. Meguro, X. Blaizot, Y. Kondoh, C. Le Mestric, J. C. Baron, and C. Chavoix Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET: Implications for Alzheimer's disease Brain, August 1, 1999; 122(8): 1519 - 1531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gotz, F. Chen, R. Barmettler, and R. M. Nitsch Tau Filament Formation in Transgenic Mice Expressing P301L Tau J. Biol. Chem., January 5, 2001; 276(1): 529 - 534. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
